FDA Inspection
Andrew C Sedillo, MDAndrew C Sedillo, MD – FDA Inspection, Jun 2, 2016
Record Details
This FDA Inspection record concerns Andrew C Sedillo, MD, with an inspection on June 2, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Andrew C Sedillo, MD
- Inspection Date
- June 2, 2016
- Product Type
- Drugs
View Company Profile
ID · 2fcc55c2-f69b-4201-a936-166cabcc80d7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 982272
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Andrew C Sedillo, MD
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 3, 2026 | Not classified | Denver District Office | Bioresearch Monitoring |
| May 7, 2025 | VAI | Denver District Office | Bioresearch Monitoring: Human Drugs |
| October 11, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 16, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Andrew C Sedillo, MD
- FDA Inspection 1334832 - 2026-09-03
- FDA Inspection 1269750 - 2025-05-07
- FDA Inspection 1108035 - 2019-10-11
- FDA Inspection 1044979 - 2018-02-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.